AdipoGen Life Sciences

RELM-β (human) Matched Pair Detection Set

CHF 750.00
In stock
AG-46A-0001-KI011 SetCHF 750.00
Reagents for 5 x 96-well plates
More Information
Product Details
Synonyms HXCP2; Resistin-like Molecule-β; FIZZ2
Product Type Kit
Properties
Application Set Quantitative ELISA
Specificity Does not cross-react with human adiponectin, mouse adiponectin, human RBP4, human Nampt, human vaspin, human GPX3, human ANGPTL3, human progranulin, human leptin, human resistin, human IL-33, human sirtuin 1, human clusterin, mouse resistin, human FABP4.
Crossreactivity Human
Quantity Contains sufficient materials to run ELISAs on 5 x 96-well plates.
Sensitivity 10pg/ml
Range 0.016 to 1ng/ml
Assay Type Sandwich
Detection Type Colorimetric
Kit Contains 1 vial standard protein (1μg) (lyophilized) [STD]
1 vial coating antibody (300μl) [COAT]
1 vial detection antibody (120μl) [DET]
1 vial anti-rabbit IgG-HRP (8μg) (lyophilized) [HRP]
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 6 months after receipt when stored at +4°C.
Documents
Manual Download PDF
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

RELM-β is a 19kDa disulfide-linked homodimeric protein expressed in the epithelium of the colon and small bowel. RELM-β has been suggested to play a regulatory role during inflammation and may also act to establish links among adipose tissue, the intestine and the liver. Interestingly, the molecular structure of RELM-β is highly homologous to that of the adipose-derived cytokine resistin.

The specific and sensitive RELM-β Matched Pair Detection Set might detect RELM-β in serum of gut-inflamed patients (e.g. inflammatory bowel diseases, Crohn disease and ulcerative colitis). Natural levels of RELM-β were seen in stool, but were not detectable in the serum or other cell culture models of healthy human patients. Further testing are ongoing.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.